Haemonetics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Haemonetics and other ETFs, options, and stocks.

About HAE

Haemonetics Corp. engages in the development and distribution of hematology products and solutions. It operates through the following segments: Plasma, Blood Center, and Hospital. 

CEO
Christopher A. Simon
CEOChristopher A. Simon
Employees
3,009
Employees3,009
Headquarters
Boston, Massachusetts
HeadquartersBoston, Massachusetts
Founded
1971
Founded1971
Employees
3,009
Employees3,009

HAE Key Statistics

Market cap
5.40B
Market cap5.40B
Price-Earnings ratio
58.27
Price-Earnings ratio58.27
Dividend yield
—
Dividend yield—
Average volume
806.24K
Average volume806.24K
High today
$124.27
High today$124.27
Low today
$116.52
Low today$116.52
Open price
$119.99
Open price$119.99
Volume
1.25M
Volume1.25M
52 Week high
$124.27
52 Week high$124.27
52 Week low
$48.17
52 Week low$48.17

Stock Snapshot

With a market cap of 5.4B, Haemonetics(HAE) trades at $117.08. The stock has a price-to-earnings ratio of 58.27.

As of 2026-10-10, Haemonetics(HAE) stock has fluctuated between $116.52 and $124.27. The current price stands at $117.08, placing the stock +0.5% above today's low and -5.8% off the high.

The Haemonetics(HAE)'s current trading volume is 1.25M, compared to an average daily volume of 806.24K.

During the past year, Haemonetics(HAE) stock moved between $48.17 at its lowest and $124.27 at its peak.

During the past year, Haemonetics(HAE) stock moved between $48.17 at its lowest and $124.27 at its peak.

HAE News

TipRanks 22h
Haemonetics price target raised to $140 from $95 at Mizuho

Mizuho analyst Anthony Petrone raised the firm’s price target on Haemonetics (HAE) to $140 from $95 and keeps an Outperform rating on the shares after the compa...

Simply Wall St 1d
Full U.S. Rollout Could Change The Case For Haemonetics Stock - Simply Wall Street

...

Full U.S. Rollout Could Change The Case For Haemonetics Stock - Simply Wall Street
Benzinga 2d
Haemonetics Stock Hits 52-Week High - Here's Why

Haemonetics Corporation (NYSE:HAE) stock surged Thursday after the company disclosed that CSL Plasma Inc. plans to deploy its NexSys PCS devices with Persona PL...

Haemonetics Stock Hits 52-Week High - Here's Why

Analyst ratings

75%

of 12 ratings
Buy
75%
Hold
25%
Sell
0%

More HAE News

TipRanks 2d
Haemonetics rises 16.0%

Haemonetics (HAE) is up 16.0%, or $16.28 to $117.99. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try...

TipRanks 2d
Why Is Haemonetics Stock Up Over 13% Today?

Haemonetics (HAE) stock was up on Thursday after the healthcare company provided investors with a business update in a Form 8-K filing with the U.S. Securities...

TipRanks 2d
Morning Movers: Haemonetics up sharply after CSL Plasma supply pact

Stock futures are lower as a renewed jump in oil prices and Treasury yields revives inflation concerns. Brent crude jumped nearly 5% to above $105 a barrel, whi...

TipRanks 2d
Haemonetics enters non-exclusive supply agreement with CSL Plasma

In a regulatory filing, Haemonetics (HAE) disclosed its entry into a non-exclusive supply agreement with CSL Plasma, under which CSL may utilize the company’s N...

TipRanks 2d
Haemonetics Expands NexSys PCS Deployment with CSL Plasma

Haemonetics ( (HAE) ) has issued an announcement. Haemonetics said it entered a non-exclusive supply agreement with CSL Plasma Inc., allowing CSL to use its Ne...

TipRanks 2d
CSL to Roll Out New Haemonetics Plasma Platform Across U.S. Network

The latest announcement is out from CSL ( (AU:CSL) ). CSL Limited has expanded its relationship with Haemonetics Corporation and plans to complete the rollout...

Simply Wall St 2d
Haemonetics Is Back In The Spotlight, What Is The Market Watching?

Haemonetics (HAE) has drawn fresh attention after recent share moves, with the price closing at US$101.71. Investors are weighing this level against the company...

Haemonetics Is Back In The Spotlight, What Is The Market Watching?

People also own

Based on the portfolios of people who own HAE. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.